Related by context. All words. (Click for frequent words.) 69 Conclusion 66 CONCLUSIONS 62 Clinical Relevance 61 Meta Analysis 60 Histologic 58 subgroup analyzes 58 Meta analyzes 58 interobserver 58 authors conclude 58 CONCLUSION 57 Localized Prostate Cancer 57 Intervention Trial 57 Main Outcome Measure 57 Clinical Outcome 57 Correlates 56 multivariate analyzes 56 Main Outcome Measures 56 Haplotype 56 Bone Mineral Density 56 Comorbidities 56 Kaplan Meier analysis 56 Univariate analysis 56 Subtypes 56 plasma pharmacokinetics 56 logistic regression analyzes 55 BERKELEY CA UroToday.com 55 epidemiologic studies 55 Randomized Controlled Trials 55 sonographic findings 55 Polymorphism 55 Predictors 55 Pharmacodynamics 55 Cytogenetic 55 Antitumor 55 Radiofrequency Ablation 54 Depressive Symptoms 54 Clinical Efficacy 54 Controlled Trial 54 Systematic Review 54 histopathological 54 multivariable analysis 54 Stent Restenosis 54 logistic regression model 54 etiologic 54 longitudinal studies 54 VNTR 54 virological response 54 psychometric properties 54 rs# [001] 54 differentially expressed genes 54 Methods 54 Histological 54 Estrogen Receptor 54 Systolic Blood Pressure 54 Long Term Outcomes 54 immunohistochemical 54 Statistically Significant 53 Phenotypes 53 Preoperative 53 Cognitive Function 53 HepG2 cells 53 urothelial carcinoma 53 Randomized Controlled Trial 53 Genotypes 53 Phylogenetic analyzes 53 #F FDG PET CT 53 Antiviral Activity 53 esophageal carcinoma 53 F FDG PET 53 prognostic significance 53 Malformations 53 Histopathologic 53 Disease Progression 53 gene polymorphisms 53 Cardiovascular Events 53 Immunohistochemical 53 prospective cohort 53 Gene Mutation 53 Randomized Evaluation 53 histologic findings 53 heterozygotes 53 Pharmacokinetic 53 Radical Prostatectomy 53 ultrastructural 53 clinicopathological 53 Myocardial Infarction 53 Supplemental Figure 53 missense mutations 53 Hemodialysis Patients 53 transient elastography 53 NICE SUGAR 53 #F FDG PET 53 HYVET 53 METHODS 53 multiple logistic regression 53 Supplementary Appendix 53 Preterm Delivery 53 Prognostic Factors 53 dimensional sonography 53 multivariate Cox 53 Septic Shock 53 Skeletal Muscle 53 chest radiographs 53 Antiviral Therapy 53 subscale scores 53 immunohistochemical analysis 53 familial aggregation 52 missense 52 univariate analysis 52 Polymorphisms 52 Mutational 52 Asymptomatic 52 cells transfected 52 HRCT 52 clinicopathologic 52 Pharmacologic 52 Malignancies 52 Pathologic 52 Tumor Cell 52 Viral Suppression 52 prepubertal 52 homozygosity 52 Infarction 52 Thrombolysis 52 renal cysts 52 Western blotting 52 Metastatic Renal Cell Carcinoma 52 Sleep Disturbance 52 Determinants 52 variance ANOVA 52 nonrandomized 52 Chronic Heart Failure 52 Randomized Study 52 Infected Patients 52 leiomyomas 52 Etiology 52 Elderly Patients 52 Carotid Stenting 52 bivariate 52 Cesarean Delivery 52 Germline 52 Radiation Dose 52 mRNA expression 52 Data Suggest 52 Appears Safe 52 Differential Diagnosis 52 correlational 52 calcaneal fractures 52 receptor antagonism 52 Coronary Artery Bypass Surgery 52 coexpression 52 SF #v# 52 orthologs 52 serological 52 Sipuleucel T 52 rs# [004] 52 Functional Outcomes 52 Contraceptive Use 52 bone scintigraphy 52 longitudinal cohort study 52 Radiation Induced 52 endoscopic ultrasonography 52 D Dimer 52 qRT PCR 52 Reperfusion 52 preoperative diagnosis 52 immunohistochemical staining 52 scintigraphy 52 Prospective Randomized Trial 52 gadolinium enhanced 52 subanalysis 52 adrenalectomy 52 acetabular dysplasia 52 Findings 52 alkaline phosphatase ALP 52 lymph node metastasis 52 meta analytic 52 Preterm Infants 52 Transcriptome 52 Cardiovascular Risk Factors 52 Obese Patients 51 COPERNICUS 51 Adjuvant Chemotherapy 51 Phenotypic 51 FDG-PET/CT 51 Predictive Value 51 lymphadenectomy 51 Ranolazine 51 Total Knee Arthroplasty 51 multivariable analyzes 51 Neoplasms 51 convergent validity 51 ANOVA 51 Supplementary Table 51 Outpatient Setting 51 Fracture Risk 51 authors hypothesized 51 FDG PET 51 Cognitive Impairment 51 Allogeneic 51 Insulin Sensitivity 51 Genetic Variation 51 Randomized Trials 51 Tumor Response 51 Multivariate analysis 51 Mechanistic 51 Improves Outcomes 51 Lesion 51 diffusion tensor 51 SOD2 51 Randomized Clinical Trial 51 Immunosuppression 51 Stent Thrombosis 51 Immunogenicity 51 Calcification 51 meta analysis 51 HER2 expression 51 Pooled Analysis 51 miRNA expression 51 subtrochanteric 51 Acute Ischemic Stroke 51 differential gene expression 51 neuroimaging studies 51 Echocardiographic 51 Atypical Hemolytic Uremic Syndrome 51 Reproducibility 51 immunocytochemistry 51 Angiographic 51 Orally Active 51 Erythropoietic 51 univariate 51 ultrasonographic 51 aminotransferase 51 VADT 51 intraobserver 51 Subgroup Analysis 51 JAK Inhibitor 51 Birth Weight 51 Phylogenetic analysis 51 Ischemic Stroke 51 Ultrasonography 51 Carotid Endarterectomy 51 androgen suppression 51 Genotype 51 polymorphisms 51 Cytotoxicity 51 methodologic 51 Beta Amyloid 51 Neuroprotective Effects 51 Androgen Receptor 51 substudy 51 Survival Rates 51 Hepatic 51 PCa 51 clinicopathological features 51 Histopathological 51 antegrade cerebral perfusion 51 Quantification 51 Monocytes 51 Monotherapy 51 Lipid Levels 51 Y Chromosome 51 ligand induced 51 Adverse Effects 51 multicentric 51 ± SEM 51 Prospective Multicenter 51 Intracerebral Hemorrhage 51 Who Underwent 51 Inhibits 51 Lymphocyte 51 Respiratory Symptoms 51 phenotype 51 Gastric Cancer 51 adenoma recurrence 51 Effective Treatments 51 Mortality Risk 50 Acute Myocardial Infarction 50 dimensional echocardiography 50 transcriptomic 50 observational studies 50 MR Angiography 50 selenium supplementation 50 Antiretroviral Therapy 50 Neuroprotection 50 CORE OM 50 Observational Study 50 interrater reliability 50 metabolite concentrations 50 logistic regressions 50 Therapy Reduces 50 Immune Responses 50 Symptom Checklist 50 Coronary Angiography 50 TRUS 50 alexithymia 50 duplex ultrasonography 50 Sleep Duration 50 Insulin Therapy 50 Cervical Spine 50 Conformational 50 Statin Therapy 50 pelvic lymphadenectomy 50 Radiation Exposure 50 Patency 50 Gastrointestinal Stromal Tumors 50 Leg Ulcers 50 C#Y 50 histopathologic 50 Gestational 50 Homogeneous 50 Systolic Hypertension 50 Premature Infants 50 Prognostic Significance 50 histologic 50 Clinical Practice Guideline 50 Ventricular 50 Kaplan Meier curves 50 Transcriptional 50 antioxidant supplementation 50 missense mutation 50 Progenitor Cells 50 echo planar 50 RCTs 50 nephron sparing surgery 50 ileal 50 Breast Cancers 50 scintigraphic 50 periprocedural MI 50 prostate cancer CaP 50 osteochondroma 50 Placebo Controlled Trial 50 Stratified 50 Infarct 50 Hematopoietic Stem Cells 50 Vertebral 50 logistic regression models 50 nodal metastases 50 Sentinel Lymph Node Biopsy 50 penetrance 50 prospective multicentre 50 Androgen 50 Psychiatric Disorders 50 Signaling Pathway 50 Renal Function 50 Prospective Cohort Study 50 vitro studies 50 immunological responses 50 Diagnostic Criteria 50 IL#B 50 Ischemic 50 Increased Risk 50 immunoreactivity 50 Clinical Trial Results 50 Heterogeneity 50 Pediatric Patients 50 #:#-# [029] 50 Distal 50 Prolonged Survival 50 serologic testing 50 Peripheral Arterial 50 pharmacodynamic PD 50 Treating Chronic 50 Preclinical Study 50 Subgroup analyzes 50 #,#-# [012] 50 null mice 50 Acute Coronary Syndromes 50 Patients Treated 50 Synthase 50 Postoperative 50 Laryngeal Cancer 50 mediated inhibition 50 Treatment Naive HIV 50 Adjuvant Therapy 50 virologic responses 50 Prospective Randomized 50 Total Hip Arthroplasty 50 extramedullary 50 Pharmacokinetic PK 50 Pharmacokinetic Study 50 Neoadjuvant Chemotherapy 50 ABCSG 50 Lipid Lowering Treatment 50 BARI 2D 50 extensive metabolizers 50 TP# mutations 50 logistic regression 50 induced sputum 50 Chronic Pelvic Pain 50 Autologous Stem Cell Transplantation 50 HRQL 50 GISSI 50 Novel Technique 50 epidemiologic 50 microsomal 50 Relapsing Remitting Multiple Sclerosis 50 Hepatocellular Carcinoma 50 Treatment Regimens 50 Coronary CTA 50 Patellofemoral 50 Morphological 50 Left Ventricular 50 antibody titer 50 Treatment Outcome 50 Neurocognitive 50 Mesothelin 50 multivariable Cox 50 Epidemiologic studies 50 mammographic density 50 Genetic Markers 50 multivariate logistic regression 50 parenchymal 50 pT2 50 Eye Diseases 50 perioperative complications 50 KRAS mutation 50 Therapy Shows Promise 50 Univariate 50 Interferon Beta 50 Attack Trial ALLHAT 50 multivariate analysis 50 Colorectal Adenomas 50 Histone 50 Pharmacological 50 metaanalysis 50 retrospective cohort 50 Significant Efficacy 50 Levels Linked 50 haplotypes 50 posttreatment 50 Survival Benefit 50 ANCOVA 50 genotypic 50 Multicentre 50 Phenotype 50 ExTRACT TIMI 50 Cardiovascular Outcomes 49 vimentin 49 Tumor Progression 49 Improve Survival 49 Molecular Weight Heparin 49 promoter polymorphism 49 T2DM 49 WOMAC scores 49 prostate carcinoma 49 transvaginal sonography 49 Overactive Bladder 49 ACER paper 49 renal tumors 49 Prostatectomy 49 HGPIN 49 Cardiogenic Shock 49 Rheumatoid Arthritis Patients 49 Coronary Syndromes 49 Severe Asthma 49 Impairs 49 CHEK2 49 Mesenchymal Stem Cells 49 generalizability 49 Adiposity 49 Cognitive Decline 49 ECLS 49 Beneficial Effects 49 tumor necrosis 49 Endometrial 49 REACH Registry 49 allelic 49 homozygotes 49 BRCA2 mutation carriers 49 Randomised 49 hypoperfusion 49 Anthropometric 49 semiquantitative 49 TIMP 1 49 Prostate Biopsy 49 interferon γ 49 Gene Variation 49 ConclusionThis 49 Multicenter 49 Postoperative Pain 49 Suicidality 49 prospectively defined 49 Patient Populations 49 MR spectroscopy 49 adrenocortical 49 OBJECTIVES 49 Aggressive Reduction 49 CEACAM1 49 Clinical Significance 49 metaplasia 49 Transgenic Mice 49 Multicenter Trial 49 perinatal outcomes 49 Surgical Treatment 49 venous thromboembolic disease 49 psychiatric morbidity 49 Intra articular 49 Cell Adhesion 49 Multicenter Study 49 Postmenopausal Women 49 MTHFR 49 Chronic Rhinosinusitis 49 Virus Infection 49 risk reducing salpingo 49 immunostaining 49 interrater 49 Acute Kidney 49 Lower Extremity 49 Nucleotide 49 phylogenetic analyzes 49 Cell Proliferation 49 covariate 49 RE LY ® 49 Therapeutic Efficacy 49 LVNC 49 Motility 49 gastric carcinoma 49 Prophylaxis 49 postoperative radiographs 49 Thrombus 49 varicoceles 49 LPS induced 49 Patients Undergoing 49 cerebellar 49 QTL mapping 49 Gene Variants 49 coinfection 49 immunocompetent 49 Carcinomas 49 plasma cortisol 49 Biological Effects 49 T1DM 49 Pearson correlation coefficients 49 Kidney Transplants 49 mechanistic insights 49 miR #a [001] 49 Glycemic Control 49 ventricular myocardium 49 Secretion 49 TIMP 49 Watchful Waiting 49 Hyperlipidemia 49 Intervention Effectiveness CATIE 49 Prostate Cancer Recurrence 49 Mitotic 49 rCBF 49 serum concentrations 49 Prolongs Survival 49 Placental 49 FDG PET CT 49 Subtype 49 Testosterone Levels 49 Protein Synthesis 49 abdominal adiposity 49 murine model 49 aetiology 49 thyrotropin 49 #:#-# [035] 49 Postprandial 49 premorbid 49 tumorigenicity 49 bivariate analysis 49 Endothelial Cells 49 Cytoplasmic 49 nonrandomized studies 49 Intracranial 49 Bare Metal Stents 49 Proves Effective 49 ECASS 49 Unfractionated Heparin 49 Breast Tumors 49 Prevent Stroke 49 multicenter trials 49 Tie2 49 Nonalcoholic Fatty Liver Disease 49 Correlative 49 prognostic variables 49 Hormone Receptor Positive 49 Bile Acid 49 Phylogenetic 49 alveolar epithelial cells 49 Myocardial Ischemia 49 surgically resected 49 Combination Therapy 49 IFN gamma 49 phylogenetic analysis 49 confounder 49 diastolic velocity 49 randomized controlled trial 49 germline mutations 49 Methodological 49 Induction Therapy 49 dyssynchrony 49 induced apoptosis 49 Immunohistochemical analysis 49 prospective observational cohort 49 pulmonary metastases 49 Cholesterol Levels 49 urolithiasis 49 #,#-# [003] 49 STRIDE PD 49 randomized controlled trials 49 preterm neonates 49 neuropathological 49 Increases Risk 49 Chronic Hepatitis C 49 pDC 49 hierarchical clustering 49 Eur Urol 49 Hepatocyte 49 radiographic findings 49 Abdominal Fat 49 thalamic 49 Inactivation 49 sonographic evaluation 49 striatal 49 randomized trials 49 Anti Tumor Activity 49 eIF2 49 randomized controlled trials RCTs 49 X Chromosome 49 Efficacy Study 49 Confirmatory 49 ST Segment Elevation 49 thrombus aspiration 49 pelvic lymph node dissection 49 Attenuates 49 Non Alcoholic Fatty 49 Dendritic Cells 49 SNP rs# [002] 49 MDRD 49 Homeostasis 49 Muscle Cells 49 hyperintensity 49 Genomic Grade 49 liver transplant recipients 49 etiology 49 TAXUS ATLAS 49 Coronary Arteries 49 epidemiological studies 49 colorectal carcinogenesis 49 Capsular 49 Subgroup analysis 49 Coronary Revascularization 49 Non Responders 49 Hemodynamic 49 Surgical Procedures 49 Alkaline Phosphatase 49 Neuronal 49 Lipoprotein 49 Kidney Function 49 Novel Inhibitor 49 mutant alleles 49 Nymox NX 49 Cannabinoid 49 Sirolimus Eluting Stent 49 retest reliability 49 Mouse Model 49 Acute Coronary 49 Endovascular Treatment 49 ELISPOT 49 haplotype 49 Arterial Hypertension 49 Protease 49 promoter methylation 49 retrospective observational study 49 Heart Failure Patients 49 inhibin B 49 Radiographic 49 Gastrointestinal Disorders 49 Urinary Catheter 49 prospective longitudinal 49 paclitaxel eluting stents 49 univariate analyzes 49 pharmacologic intervention 48 Prostatic 48 HCV SPRINT 48 microsatellite instability 48 LNCaP cells 48 observational cohort study 48 Prognostic Value 48 Evoked 48 Hemolysis 48 Reduce Mortality 48 gene polymorphism 48 hereditary hemochromatosis 48 Resection 48 serologic 48 angiographically 48 hypogonadotropic hypogonadism 48 Observational Studies 48 FDG uptake 48 meta regression 48 Pregnancy Outcomes 48 regression equations 48 interobserver reliability 48 Radiographs 48 #q#.# [001] 48 pleiotropic effects 48 KLF4 48 Tolerability 48 Cardiac Allograft Rejection 48 antibiotic prophylaxis 48 Left Ventricular Dysfunction 48 Differentially 48 radicular 48 interobserver agreement 48 Nephropathy 48 J Clin Oncol 48 intravesical therapy 48 Intubation 48 Highly Selective 48 Intracranial Aneurysms 48 Transurethral 48 bladder carcinoma 48 receptor kinase 48 prespecified secondary 48 OPCAB 48 Transcription Factor 48 Iron Deficiency 48 Sonography 48 Intracoronary 48 Uterine 48 mean ± SEM 48 Protease Inhibitors 48 somatic mutations 48 Cardiac Function 48 Viral Load 48 Endogenous 48 cTnI 48 Stem Cell Transplants 48 susceptibility loci 48 transabdominal 48 oncologic outcomes 48 Hypertensive Patients 48 Disease Severity 48 renal artery stenosis 48 Lung Injury 48 virologic 48 adjuvant therapies 48 HIV HCV coinfected 48 Venous Thrombosis 48 antimicrobial prophylaxis 48 β blockers 48 Screening Mammography 48 Percutaneous Coronary Intervention 48 Metastases 48 Postmenopausal Hormone Therapy 48 Efficacious 48 Calcium Intake 48 Double Blind Randomized 48 Metastatic Colorectal Cancer 48 Knee Osteoarthritis 48 prognostic indicator 48 multivariable logistic regression 48 underwent resection 48 hallux valgus 48 susceptibility locus 48 Dose Response 48 meta analyzes 48 Arch Neurol 48 humoral responses 48 sleeve lobectomy 48 Randomized controlled 48 Endothelial Function 48 PFPS 48 Long Term Efficacy 48 Demonstrates Efficacy 48 Binding Protein 48 KRAS status 48 Attenuated 48 chronicity 48 biopsy specimens 48 RRM1 48 Kaplan Meier curve 48 Iron Overload 48 Stepwise 48 ERalpha 48 Negative Effects 48 Aortic Valve 48 Oral Fingolimod 48 Tonsillectomy 48 Microtubule 48 CCR9 48 unicompartmental knee arthroplasty 48 Cardiovascular Risk 48 Combination Treatment 48 indirect immunofluorescence 48 BPS IC 48 linkage disequilibrium LD 48 Antitumor Activity 48 Erosive 48 Results Indicate 48 genes differentially expressed 48 CIN2 + 48 resected pancreatic cancer 48 Adverse Event 48 nomograms 48 cAMP signaling 48 transgenic mouse models 48 Prevalence 48 subclinical hypothyroidism 48 splenic 48 Ki# 48 Immunologic 48 Prostate Cancer Outcomes 48 Controlled Study 48 Transcranial 48 serum cortisol 48 H pylori 48 Chronic HCV 48 Anticoagulation 48 Suboptimal 48 autonomic dysfunction 48 gastric adenocarcinoma 48 Improves Survival 48 transgene expression 48 Proliferative 48 Tumor Cells 48 spirometric 48 adjuvant radiotherapy 48 depressive symptomatology 48 prucalopride 48 Liver Failure 48 histologically proven 48 Castration Resistant Prostate Cancer 48 EuroSCORE 48 Gastrointestinal Tract 48 karyotypes 48 Adjuvant 48 Pluripotent Stem Cells 48 Inhaled Corticosteroids 48 sonographic 48 FASEB J. 48 Comorbidity 48 Breast Carcinoma 48 urothelium 48 Cyclic 48 papillary thyroid carcinoma 48 Vps# 48 Catheter Ablation 48 etiologic factors 48 Randomized trials 48 anthropometric measurements 48 Digestive Tract 48 Metastatic Prostate Cancer 48 Polyp Prevention Trial 48 annexin 48 femoral neck fractures 48 Ischemic Heart Disease 48 Lung Function 48 Dyspnea 48 esophageal squamous cell carcinoma 48 β1 48 Serologic 48 TOP2A 48 arthrodesis 48 PROactive study 48 upregulation 48 Antihypertensive 48 SORT OUT III 48 DNA methylation markers 48 Randomized Clinical Trials 48 Pharmacogenetic 48 Immunohistochemistry 48 Brain Stimulation 48 Inflammatory Markers 48 ultrasonography 48 inverse association 48 HRQOL 48 Epidemiologic 48 FOR AN OPEN 48 IPAH 48 autoregulation 48 Diabetic Patients 48 CXCR4 expression 48 Smooth Muscle 48 Prognostic factors 48 Conjugated 48 hyperintensities 48 #:#-# [031] 48 Cerebral Cortex 48 MLH1 48 Coronary artery bypass grafting 48 Clinical Evaluation 48 #:#-# [028] 48 reflux esophagitis 48 retrospective cohort study 48 LRTI 48 intracranial hypertension 48 BOLDER II 48 hypothalamic pituitary adrenal axis 48 Duodenal 48 arthrography 48 Tyrosine Kinase Inhibitor 48 Logistic regression analysis 48 logistic regression analysis 48 NOD mouse 48 Quantitation 48 Long Term Survival 48 Cognitive Dysfunction 48 Microalbuminuria 48 Secretase 48 Cochrane Systematic Review 48 synteny 48 Jhdm2a 48 Comparative Analysis 48 parathyroidectomy 48 Therapeutic Potential 48 Hepatotoxicity 48 activating mutation 48 antidepressant efficacy 48 Cause Mortality 48 prospective multicenter study 48 thyrotropin levels 48 pretest probability 48 Critically Ill Patients 48 STICH trial 48 Rosiglitazone Evaluated 48 Epithelial Cell 48 IFN α 48 Ectopic 48 Dual Antiplatelet Therapy 48 Vertebroplasty 48 Hospitalized Patients 48 ESR1 48 postoperative complication 48 CagA 48 Myocardial Perfusion 48 Respiratory Virus 48 Multivariate logistic regression 48 Thrombotic 48 etiologic agent 48 genetic loci 48 See CLINICAL PHARMACOLOGY 48 serologic tests 48 immunoblot 48 Postmenopausal 48 neuropathologic 48 confidence intervals CIs 48 psychiatric comorbidity 48 hENT1 48 BHIVA 48 genetic polymorphisms 48 Risk Stratification 48 Breast Cancer Recurrence 48 prognostic markers 48 morphometry 48 CAMMS# 48 #-# Full Text 48 fetal echocardiography 48 radiographic evaluation 48 lymphovascular invasion 48 variant alleles 48 KIF6 gene 48 platelet reactivity 48 Psychiatric Illness 48 Chronic Insomnia 48 Chemotherapeutic Agents 48 immunofluorescence 48 biochemical recurrence 48 bronchial epithelial cells 48 Heritability 48 Recurrence 48 Ann Emerg Med 48 oligomerization 48 Could Prevent 48 Improve Outcomes 48 BRAF V#E 48 apolipoproteins 48 Retrovirus 48 LDL Cholesterol 48 DLC1 48 Therapeutic Effects 48 morphometric 48 Thromboembolism 48 Serum concentrations 48 Liver Fibrosis 48 Meta Analyses 48 Abnormality 48 Tomographic 48 Insulin Resistance 48 T1a 48 vesicoureteral reflux 48 DHA supplementation 48 acetabular fracture 48 dinucleotide 47 Protein Interactions 47 cytokeratin 47 Predict Response 47 serum folate concentrations 47 Cytochrome P# 47 Suicidal Ideation 47 constitutively expressed 47 Colorectal Cancer Risk 47 airway hyperresponsiveness 47 hepatic cirrhosis 47 Patients Receiving